Dosing Experiments

From QMRAwiki
Jump to: navigation, search

This is a master list of dosing experiments. Many of these have been used to fit dose response models, but others have not. You can sort by column to find what you need. You can also hit control-f to find what you need. The Expt Id link will take you directly to the data set if available. The 'dose response fit' column has 4 values: fitted (it's been used to fit a dose response model), pooled (it's contributed to a dose response model), not fittable (definition needed), or not yet in wiki (the data exists, but has not yet been added to the wiki). Clicking on fitted or pooled will take you to the Dose Response model page for the agent. The Pathogen link will take you the Agent Overview page, if one exists.

Bacteria category test page

Expt ID Agent Pathogen Pathogen Type Host Host Type Host Characteristics Route Response Dose Units Reference Dose ResponseFit
1 Bacterium Yersinia pestis CO92 mouse C57BL/6 intranasal death CFU [1] fitted
2 Bacterium Yersinia pestis KIM D27 mouse C57BL/6 intranasal death CFU [2] fitted
3 Bacterium Yersinia pestis CO92 mouse BALB/c intraperitoneal death CFU [3] fitted
4 Bacterium Yersinia pestis 195/P langur Presbytis entellus subcutaneous death CFU [4] not yet in wiki
5 Bacterium Yersinia pestis 195/P langur Presbytis cristata subcutaneous death CFU [5] not fittable
6 Bacterium Yersinia pestis 195/P grivet subcutaneous death CFU [6] not yet in wiki
7 Bacterium Yersinia pestis monkey rhesus inhalation death Average no. organisms inhaled [7] not yet in wiki
8 Bacterium Yersinia pestis Alexander mouse albino intracutaneous death CFU [8] not yet in wiki
9 Bacterium Variola major mouse aged 0-24 hours intraperitoneal death pock forming unit [9] fitted
10 Bacterium Variola major mouse aged 24-48 hours intraperitoneal death pock forming unit [10] fitted
11 Bacterium Variola major mouse aged 48-120 hours intraperitoneal death pock forming unit [11] fitted
12 Bacterium Variola major mouse aged 120-168 hours intraperitoneal death pock forming unit [12] fitted
13 Virus Lassa virus guinea pig inbred, USAMRIID strain 13 450-600g subcutaneous PFU [13] fitted
14 Virus Lassa virus guinea pig outbred, Hartley strain 450-500g subcutaneous PFU [14] not yet in wiki
15 Virus Lassa virus guinea pig outbred, Hartley strain 180-300g inhalation death PFU [15] fitted
16 Virus Lassa virus guinea pig outbred, Hartley strain 180-300g inhalation morbidity PFU [16] not fittable
17 Bacterium Burkholderia pseudomallei KHW mouse BALB/c female, age 5-6w intranasal CFU [17] fitted
18 Bacterium Burkholderia pseudomallei KHW mouse C57BL/6 female, age 5-6w intranasal CFU [18] fitted
19 Bacterium Burkholderia mallei SR1 hamster Syrian intraperitoneal death CFU [19] not fittable
20 Bacterium Burkholderia mallei tssE-/tssE+ hamster Syrian intraperitoneal death CFU [20] not yet in wiki
21 Bacterium Burkholderia pseudomallei W294 guinea pig intraperitoneal death CFU [21] fitted
22 Bacterium Burkholderia mallei C7 guinea pig intraperitoneal death CFU [22] not fittable
23 Bacterium Burkholderia pseudomallei 316c rat outbred, Sprague-Dawley 30g, diabetic intraperitoneal death CFU [23] not yet in wiki
24 Bacterium Coxiella burnetii Nine mile phase I guinea pig outbred, Hartley strain female, age 6-8w inhalation fever no. organisms [24] not fittable
25 Bacterium Coxiella burnetii Nine mile phase I mouse SCID intraperitoneal death TCID50 doses [25] not yet in wiki
26 Bacterium Coxiella burnetii Nine mile phase I mouse C57BL/6J intraperitoneal death no. organisms [26] fitted
27 Bacterium Coxiella burnetii Nine mile phase I mouse A/J intraperitoneal death no. organisms [27] not fittable
28 Bacterium Coxiella burnetii phase I Ohio mouse C57BL/10ScN male intraperitoneal death no. organisms [28] fitted
29 Bacterium Coxiella burnetii phase I AD human male, young adult inhalation clinical signs guinea pig infectious dose [29] not yet in wiki
30 Virus adenovirus APC human inhalation infection [30] not fittable
31 Virus adenovirus type 4 inhalation [31] fitted
32 Virus astrovirus human oral [32] not fittable
33 Bacterium Vibrio cholerae classical [33] not fittable
34 Bacterium Vibrio cholerae El Tor [34] not fittable
35 Bacterium Vibrio cholerae Inaba 569B human adult male prisoners oral (no NaHCO3) diarrhea or culture positive CFU [35] fitted
36 Protozoan Cryptosporidium parvum morbidity [36] not fittable
37 Bacterium cyanobacteria mouse [37] not fittable
38 Bacterium Escherichia coli ETEC B7A human male prisoner oral (in milk) mild to severe diarrhea cells [38] pooled
39 Bacterium Escherichia coli EIEC 4608 human male prisoner oral (in milk) mild to severe diarrhea cells [39] fitted
40 Bacterium Escherichia coli EIEC 1624 human male prisoner oral (in milk) mild to severe diarrhea cells [40] fitted
41 Bacterium Escherichia coli EIEC 1624 human male prisoner oral (w. 2g NaHCO3) severe diarrhea cells [41] not fittable
42 Bacterium Escherichia coli ETEC O55 (in paper as “type 55, B5”) human male prisoner oral slight to severe illness organisms [42] fitted
43 Bacterium Escherichia coli ETEC O111 (in paper as “E. coli 111, B4”) human male prisoner oral slight to severe illness organisms [43] fitted
44 Virus echovirus 12 human infection [44] not yet in wiki
45 Protozoan Endamoeba coli From an infected human human male prisoner oral infection no. cysts [45] fitted
46 Protozoan Giardia sp. From an infected human human male prisoner oral infection no. cysts [46] fitted
47 Protozoan Giardia sp. From infected humans beaver trapped near Minneapolis oral infection no. cysts [47] fitted
48 Protozoan Giardia sp. From infected humans muskrat trapped near Minneapolis stomach tube infection no. cysts [48] fitted
49 Protozoan Giardia sp. unknown human visitors & residents of Aspen Highlands, CO oral diarrhea glasses of water [49] not fittable
50 Bacterium Giardia muris mouse C3H/H3N specific-pathogen-free, 6-8 week old male mice oral infection cysts [50] not yet in wiki
51 Virus hepatitis A From an infected human human child “mentally defective” 5-10 year olds oral jaundice equivalents to grams of stool [51] not yet in wiki
52 Virus hepatitis A From an infected human human child “mentally defective” 5-10 year olds oral jaundice equivalents to grams of stool [52] not yet in wiki
53 Virus parainfluenza virus type 2 human adult infection [53] not yet in wiki
54 Virus parainfluenza virus type 2 human adult morbidity [54] not yet in wiki
55 Virus parainfluenza virus type 3 hamster [55] not yet in wiki
56 Virus poliovirus type 1, attenuated [56] not yet in wiki
57 Virus poliovirus type 1, attenuated human infant infection [57] not fittable
58 Virus poliovirus type 2, attenuated [58] not yet in wiki
59 Virus poliovirus type 2 [59] not fittable
60 Virus poliovirus type 3, attenuated human [60] not fittable
61 Virus poliovirus type 2 [61] not yet in wiki
62 Virus enterovirus porcine, PE3-ECPO-6 pig [62] fitted
63 Virus enterovirus porcine, PE7-05i pig [63] fitted
64 Virus rhinovirus type 14 human [64] fitted
65 Virus rhinovirus type 39 human [65] fitted
66 Virus rotavirus OSU pig specific-pathogen-free, colostrum-deprived, caesarean-derived newborn piglets oral infection PFU [66] not fittable
67 Virus rotavirus MET strain, serotype 3, subgroup II mouse Swiss SW55 newborn oral infection TCID50 doses [67] not yet in wiki
68 Virus rotavirus OSU (ATCC VR892) pig 4-5 day old colostrum-deprived piglets intragastric infection particles [68] fitted
69 Virus rotavirus CJN strain (unpassaged) human healthy 18-45 year old men oral infection FFU [69] fitted
70 Virus rotavirus CJN strain (unpassaged) human healthy 18-45 year old men oral symptoms and infection FFU [70] fitted
71 Virus respiratory syncytial virus nasal [71] not yet in wiki
72 Virus respiratory syncytial virus ocular [72] not yet in wiki
73 Virus respiratory syncytial virus oral [73] not fittable
74 Virus respiratory syncytial virus [74] not fittable
75 Virus respiratory syncytial virus attenuated [75] not fittable
76 Virus rubella virus [76] not fittable
77 Bacterium Salmonella typhosa [77] not fittable
78 Bacterium Salmonella typhosa Quailes human prisoners oral (in milk) disease CFU [78] fitted
79 Bacterium Salmonella typhosa Quailes human prisoners oral (in milk) disease CFU [79] fitted
80 Bacterium Shigella dysenteriae M 131 human young adult male prisoners oral (in milk) illness organisms [80] fitted
81 Bacterium Shigella flexneri 2a (strain 2457T) human healthy male prisoners oral (in milk) illness CFU [81] fitted
82 Bacterium Shigella flexneri 2a (strain 2457T) human healthy male prisoners oral (in milk) positive stool isolation CFU [82] fitted
83 Bacterium Bacillus anthracis Vollum guinea pig inhalation death spores [83] fitted
84 Bacterium Bacillus anthracis ATCC 6605 guinea pig inhalation death spores [84] fitted
85 Bacterium Bacillus anthracis Vollum monkey rhesus inhalation death spores [85] fitted
86 Bacterium Bacillus anthracis Vollum guinea pig inhalation death spores [86] fitted
87 Bacterium Escherichia coli ETEC O55 (in paper as “type 55, B5”) human male prisoner oral moderate to severe illness organisms [87] not fittable
88 Bacterium Escherichia coli ETEC O111 (in paper as “E. coli 111, B4”) human male prisoner oral moderate to severe illness organisms [88] not fittable
89 Protozoan Aeromonas hydrophila 6Y human healthy adult volunteer oral shedding in feces CFU [89] not fittable
90 Protozoan Aeromonas hydrophila 6Y human healthy adult volunteer oral diarrhea CFU [90] not fittable
91 Protozoan Aeromonas hydrophila 3647 human healthy adult volunteer oral shedding in feces CFU [91] not fittable
92 Protozoan Aeromonas hydrophila 3647 human healthy adult volunteer oral diarrhea CFU [92] not fittable
93 Protozoan Aeromonas hydrophila B158, SSU, & 3284 human healthy adult volunteer oral shedding in feces CFU [93] not fittable
94 Protozoan Aeromonas hydrophila B158, SSU, & 3284 human healthy adult volunteer oral diarrhea CFU [94] not fittable
95 Bacterium Escherichia coli ETEC B7A human male prisoner oral (in milk) positive stool isolation cells [95] pooled
96 Bacterium Escherichia coli EIEC 4608 human male prisoner oral (in milk) positive stool isolation cells [96] not fittable
97 Bacterium Escherichia coli EIEC 1624 human male prisoner oral (in milk) positive stool isolation cells [97] fitted
98 Bacterium Escherichia coli ETEC B2C human male prisoner oral (in milk) mild to severe diarrhea cells [98] pooled
99 Bacterium Escherichia coli ETEC B2C human male prisoner oral (in milk) positive stool isolation cells [99] pooled
100 Bacterium Escherichia coli HS (nonenteropathogenic) human male prisoner oral (in milk) mild to severe diarrhea cells [100] not fittable
101 Bacterium Escherichia coli HS (nonenteropathogenic) human male prisoner oral (in milk) positive stool isolation cells [101] not fittable
102 Bacterium Pseudomonas aeruginosa human 29-35 year old lab workers oral positive stool isolation CFU [102] not fittable
103 Bacterium Salmonella enterica serovar meleagridis, strain III human male prisoner oral positive stool isolation organisms [103] not yet in wiki
104 Bacterium Salmonella enterica serovar meleagridis, strain III human male prisoner oral infection organisms [104] not yet in wiki
105 Bacterium Campylobacter jejuni strain A3249 human young adult oral (in milk) infection CFU [105] fitted
106 Bacterium Campylobacter jejuni strain A3249 human young adult oral (in milk) fever, vomiting, or diarrhea CFU [106] not fittable
107 Bacterium Cryptosporidium parvum Iowa strain human healthy university students & staff oral infection oocysts [107] fitted
108 Bacterium Cryptosporidium parvum Iowa strain human healthy university students & staff oral infection and enteric symptoms oocysts [108] not fittable
109 Virus poliovirus 1 (Sabin) infection [109] not yet in wiki
110 Virus poliovirus 3 (Fox) infection [110] not fittable
111 Virus echovirus 12 human [111] not fittable
112 Virus coxsackievirus B4 mouse newborn aerosol death intraperitoneal LD50 / 0.03 mL [112] not fittable
113 Virus coxsackievirus A21 (49882 HEK1) human healthy adult males aerosol infection TCID50 doses [113] not yet in wiki
114 Virus coxsackievirus A21 (49882 HEK1) human healthy adult males aerosol illness TCID50 doses [114] not fittable
115 Virus coxsackievirus A21 (48654 HEF2) human healthy adult males aerosol infection TCID50 doses [115] not yet in wiki
116 Virus coxsackievirus A21 (48654 HEF2) human healthy adult males aerosol illness TCID50 doses [116] not fittable
117 Virus coxsackievirus A21 human healthy adult male prisoners 0.3-2.5 micron aerosol illness TCID50 doses [117] not yet in wiki
118 Virus coxsackievirus A21 human no antibody healthy adult male prisoners combined aerosol and nasal illness TCID50 doses [118] not fittable
119 Virus coxsackievirus A21 human intermediate antibody healthy adult male prisoners combined aerosol and nasal illness TCID50 doses [119] not fittable
120 Virus coxsackievirus A21 human high antibody healthy adult male prisoners combined aerosol and nasal illness TCID50 doses [120] not fittable
121 Virus coxsackievirus A21 human no antibody healthy adult male prisoners combined aerosol and nasal infection TCID50 doses [121] not fittable
122 Virus coxsackievirus A21 human intermediate antibody healthy adult male prisoners combined aerosol and nasal infection TCID50 doses [122] not fittable
123 Virus coxsackievirus A21 human high antibody healthy adult male prisoners combined aerosol and nasal infection TCID50 doses [123] not fittable
124 Virus rotavirus CJN strain (unpassaged) human healthy 18-45 year old men oral detectable shedding FFU [124] fitted
125 Bacterium Vibrio cholerae Inaba 569B human adult male prisoners oral (w. NaHCO3) any diarrhea CFU [125] fitted
126 Bacterium Vibrio cholerae Inaba 569B human adult male prisoners oral (w. NaHCO3) ordinary diarrhea CFU [126] not fittable
127 Bacterium Vibrio cholerae Inaba 569B human adult male prisoners oral (w. NaHCO3) cholera diarrhea CFU [127] fitted
128 Bacterium Salmonella enterica serovar meleagridis, strain II human male prisoner oral positive stool isolation organisms [128] not yet in wiki
129 Bacterium Salmonella enterica serovar meleagridis, strain I human male prisoner oral positive stool isolation organisms [129] not yet in wiki
130 Bacterium Salmonella enterica serovar meleagridis, strain I human male prisoner oral infection organisms [130] not yet in wiki
131 Bacterium Salmonella enterica serovar anatum, strain I human male prisoner oral positive stool isolation organisms [131] not yet in wiki
132 Bacterium Salmonella enterica serovar anatum, strain I human male prisoner oral infection organisms [132] not fittable
133 Bacterium Salmonella enterica serovar anatum, strain I human male prisoner oral positive stool isolation organisms [133] not fittable
134 Bacterium Salmonella enterica serovar anatum, strain I human male prisoner oral positive stool isolation organisms [134] not yet in wiki
135 Bacterium Salmonella enterica serovar anatum, strain I human male prisoner oral infection organisms [135] not fittable
136 Bacterium Campylobacter jejuni strain 81-176 human young adult oral (in milk) infection CFU [136] not yet in wiki
137 Bacterium Campylobacter jejuni strain 81-176 human young adult oral (in milk) diarrhea or fever CFU [137] not fittable
138 Protozoan Cryptosporidium parvum Iowa isolate human healthy adults oral infection oocysts [138] fitted
139 Protozoan Cryptosporidium parvum TAMU isolate human healthy adults oral infection oocysts [139] fitted
140 Protozoan Cryptosporidium parvum UCP isolate human healthy adults oral infection oocysts [140] fitted
141 Bacterium Escherichia coli ETEC B7A human healthy adults oral (w. NaHCO3) diarrhea CFU [141] pooled
142 Bacterium Escherichia coli ETEC H10407 (ST< O78:H11) human healthy adults oral (w. NaHCO3) diarrhea CFU [142] pooled
143 Bacterium Escherichia coli ETEC H10407 (ST< O78:H11) human healthy adults oral (w. 2g NaHCO3) diarrhea CFU [143] pooled
144 Bacterium Escherichia coli ETEC B7A (O148:H28) human healthy adults oral (w. 3g NaHCO3) diarrhea organisms [144] pooled
145 Bacterium Escherichia coli ETEC B7A (O148:H28) human healthy adults oral (w. 3g NaHCO3) positive stool culture organisms [145] not fittable
146 Bacterium Escherichia coli ETEC B7A (O148:H28) human healthy adults oral (w. 3g NaHCO3) diarrhea organisms [146] pooled
147 Bacterium Escherichia coli ETEC B7A (O148:H28) human healthy adults oral (w. 3g NaHCO3) positive stool culture organisms [147] not fittable
148 Bacterium Escherichia coli ETEC B7A (O148:H28) human healthy adults oral (w. 3g NaHCO3) diarrhea organisms [148] not fittable
149 Bacterium Escherichia coli ETEC B7A (O148:H28) human healthy adults oral (w. 3g NaHCO3) positive stool culture organisms [149] not fittable
150 Bacterium Escherichia coli ETEC E2528-C1 (O25:NM) human healthy adults oral (w. 3g NaHCO3) diarrhea organisms [150] pooled
151 Bacterium Escherichia coli ETEC E2528-C1 (O25:NM) human healthy adults oral (w. 3g NaHCO3) positive stool culture organisms [151] not fittable
152 Bacterium Escherichia coli EPEC E2348/69 (O127:H6) human healthy adults oral (w. 2g NaHCO3) diarrhea CFU [152] pooled
153 Bacterium Escherichia coli EPEC E2348/69 (O127:H6) human healthy adults oral (w. 2g NaHCO3) shedding in feces CFU [153] pooled
154 Bacterium Escherichia coli EPEC 2362-75 (O55:H6) human healthy adults oral (w. 2g NaHCO3) diarrhea CFU [154] not fittable
155 Bacterium Escherichia coli EPEC 2362-75 (O55:H6) human healthy adults oral (w. 2g NaHCO3) positive stool culture CFU [155] pooled
156 Bacterium Escherichia coli EPEC E2348/69 (O127:H6) human healthy adults oral (w. 2g NaHCO3) diarrhea CFU [156] pooled
157 Bacterium Escherichia coli EPEC E2348/69 (O127:H6) human healthy adults oral (w. 2g NaHCO3) positive stool culture CFU [157] pooled
158 Bacterium Escherichia coli EPEC E2348/69 (O127:H6) human healthy adults oral (w. 2g NaHCO3) diarrhea CFU [158] pooled
159 Bacterium Escherichia coli EPEC E2348/69 (O127:H6) human healthy adults oral (w. 2g NaHCO3) positive stool culture CFU [159] pooled
160 Bacterium Escherichia coli ETEC 214-4 (ST) human healthy adults oral (w. 2g NaHCO3) diarrhea organisms [160] pooled
161 Bacterium Escherichia coli ETEC TD225-C4 (LT) human healthy adults oral (w. 2g NaHCO3) diarrhea organisms [161] pooled
162 Bacterium Escherichia coli ETEC H10407 (ST< O78:H11) human healthy adults oral (w. 2g NaHCO3) diarrhea organisms [162] pooled
163 Bacterium Escherichia coli ETEC B7A (ST< O148:H28) human healthy adults oral (w. 2g NaHCO3) diarrhea organisms [163] pooled
164 Bacterium Escherichia coli ETEC 214-4 (ST) human healthy adults oral (in milk) diarrhea or vomiting organisms [164] fitted
165 Bacterium Escherichia coli ETEC 214-4 (ST) human healthy adults oral (in milk) positive stool culture organisms [165] fitted
166 Bacterium Vibrio cholerae Inaba 569B (classical) human adult male prisoners oral (no NaHCO3) diarrhea and culture positive CFU [166] fitted
167 Bacterium Escherichia coli ETEC H10407 (ST< O78:H11) human healthy adults oral (w. 2g NaHCO3) diarrhea organisms [167] pooled
168 Bacterium Escherichia coli ETEC B7A (ST< O148:H28) human healthy adults oral (w. 2g NaHCO3) diarrhea organisms [168] pooled
169 Bacterium Escherichia coli ETEC H10407 (ST< O78:H11) human healthy adults oral (w. 2g NaHCO3) diarrhea organisms [169] pooled
170 Bacterium Escherichia coli ETEC H10407 (ST< O78:H11) human healthy adults oral (w. 2g NaHCO3) diarrhea organisms [170] not fittable
171 Bacterium Escherichia coli ETEC 214-4 (ST) human healthy adults oral (w. 2g NaHCO3) diarrhea organisms [171] pooled
172 Virus norovirus 8fIIa (aggregated virions) human positive secretor status (Se+) oral infection (shedding & seroconversion) genomes [172] not yet in wiki
173 Virus norovirus 8fIIb (dispersed virions) human positive secretor status (Se+) oral infection (shedding & seroconversion) genomes [173] not yet in wiki
174 Virus norovirus 8fIIa (aggregated virions) human positive secretor status (Se+) oral diarrhea/vomiting genomes [174] not yet in wiki
175 Virus norovirus 8fIIb (dispersed virions) human positive secretor status (Se+) oral diarrhea/vomiting genomes [175] not fittable
176 Bacterium Escherichia coli EHEC UC741 (O157:H7) rabbit 3 day old intragastric (w. NaHCO3) diarrhea CFU [176] fitted
177 Bacterium Escherichia coli EHEC UC741 (O157:H7) rabbit 3 day old intragastric (w. NaHCO3) severe diarrhea CFU [177] not yet in wiki
178 Bacterium Escherichia coli EHEC UC741 (O157:H7) rabbit 3 day old intragastric (w. NaHCO3) death CFU [178] not yet in wiki
179 Protozoan Cryptosporidium hominis TU502 human healthy adults oral infection oocysts [179] not fittable
180 Protozoan Cryptosporidium hominis TU502 human healthy adults oral diarrhea oocysts [180] fitted
181 Protozoan Cryptosporidium parvum Moredun isolate human healthy adults oral diarrhea oocysts [181] not fittable
182 Protozoan Cryptosporidium parvum Moredun isolate human healthy adults oral infection oocysts [182] fitted
183 Bacterium Campylobacter jejuni type strain for serotype PEN 1 mouse HA-ICR adult female intragastric infection CFU [183] fitted
184 Bacterium Campylobacter jejuni type strain for serotype PEN 2 mouse HA-ICR adult female intragastric infection CFU [184] fitted
185 Bacterium Campylobacter jejuni type strain for serotype PEN 3 mouse HA-ICR adult female intragastric infection CFU [185] fitted
186 Bacterium Campylobacter jejuni strain CG8421 human healthy adults oral (w. bicarbonate) campylobacteriosis CFU [186] not fittable
187 Bacterium Campylobacter jejuni strain 81-176 human healthy adults oral (w. 2g NaHCO3) campylobacteriosis CFU [187] fitted
188 Bacterium Campylobacter jejuni strain A3249 human young adult oral (in milk) infection CFU [188] not yet in wiki
189 Bacterium Campylobacter jejuni strain A3249 human young adult oral (in milk) diarrhea or fever CFU [189] not fittable
190 Bacterium Campylobacter jejuni strain 480 chicken Wickham shedding in feces CFU [190] not yet in wiki
191 Bacterium Campylobacter jejuni strain 466 chicken Lohmann shedding in feces CFU [191] not fittable
192 Bacterium Campylobacter jejuni strain P5444 chicken Lohmann shedding in feces CFU [192] not fittable
193 Bacterium Campylobacter jejuni strain P5623 chicken Lohmann shedding in feces CFU [193] not fittable
194 Bacterium Campylobacter jejuni strain 119a chicken Lohmann shedding in feces CFU [194] not fittable
195 Bacterium Campylobacter jejuni strain 121a chicken Lohmann shedding in feces CFU [195] not fittable
196 Bacterium Campylobacter jejuni strain 123a chicken Lohmann shedding in feces CFU [196] not fittable
197 Bacterium Campylobacter coli UA585 chicken Wickham shedding in feces CFU [197] not fittable
198 Bacterium Campylobacter jejuni strain 93/146 chicken Wickham shedding in feces CFU [198] not fittable
199 Bacterium Campylobacter jejuni strain 94/146 chicken Wickham shedding in feces CFU [199] not fittable
200 Bacterium Campylobacter jejuni strain 93175 chicken Wickham shedding in feces CFU [200] not fittable
201 Bacterium Campylobacter jejuni strain 0087 chicken Lohmann shedding in feces CFU [201] not yet in wiki
202 Bacterium Campylobacter jejuni strain 81116P chicken Wickham shedding in feces CFU [202] not yet in wiki
203 Bacterium Campylobacter jejuni strain R3P chicken Wickham shedding in feces CFU [203] not fittable
204 Bacterium Campylobacter jejuni strain 81-176 chicken Wickham shedding in feces CFU [204] not fittable
205 Bacterium Campylobacter jejuni strain 81-176 chicken Lohmann shedding in feces CFU [205] not fittable
206 Bacterium Campylobacter jejuni strain 11168 chicken Wickham shedding in feces CFU [206] not fittable
207 Bacterium Campylobacter jejuni strain 11168 chicken Lohmann shedding in feces CFU [207] not yet in wiki
208 Bacterium Campylobacter jejuni strain R3 chicken Wickham shedding in feces CFU [208] not fittable
209 Bacterium Campylobacter jejuni strain 81116 chicken Wickham shedding in feces CFU [209] not yet in wiki
210 Bacterium Campylobacter jejuni strain 81116 chicken Lohmann shedding in feces CFU [210] not yet in wiki
211 Bacterium Campylobacter jejuni strain 81117 chicken Lohmann shedding in feces CFU [211] fitted
212 Bacterium Escherichia coli EHEC O157:H7, strain 86-24 pig 3 month old oral (in food) shedding in feces CFU [212] fitted
213 Bacterium Escherichia coli EPEC B171-8 (serotype O11:NM) human healthy adults oral (w. NaHCO3) diarrhea CFU [213] pooled
214 Bacterium Shigella dysenteriae A-1 human young adult male prisoners oral (in milk) illness organisms [214] pooled
215 Bacterium Escherichia coli EPEC E2348/69 (O127:H6) human healthy adults oral (w. 2g NaHCO3) diarrhea CFU [215] pooled
216 Bacterium Escherichia coli EPEC E851/71 (O142:H6) human healthy adults oral (w. 2g NaHCO3) diarrhea CFU [216] pooled
217 Bacterium Escherichia coli EPEC E74/68 (O128:H2) human healthy adults oral (w. 2g NaHCO3) diarrhea CFU [217] not fittable
218 Bacterium Escherichia coli EPEC E2348/69 (O127:H6) human healthy adults oral (w. 2g NaHCO3) positive stool culture CFU [218] pooled
219 Bacterium Escherichia coli EPEC E851/71 (O142:H6) human healthy adults oral (w. 2g NaHCO3) positive stool culture CFU [219] pooled
220 Bacterium Escherichia coli EPEC E74/68 (O128:H2) human healthy adults oral (w. 2g NaHCO3) positive stool culture CFU [220] pooled
221 Bacterium Escherichia coli ETEC H10407 (O78:H11) human healthy adults oral (w. 2g NaHCO3) diarrhea CFU [221] not fittable
222 Bacterium Shigella flexneri 2a (strain 2457T) human healthy male prisoners oral (in milk) illness CFU [222] fitted
223 Bacterium Shigella sonnei 53G human healthy male prisoners oral (in milk) illness CFU [223] pooled
224 Bacterium Shigella sonnei 53G human healthy male prisoners oral (in milk) illness CFU [224] pooled
225 Bacterium Campylobacter jejuni strain A3249 human young adult oral (w. 2g NaHCO3) infection CFU [225] not fittable
226 Bacterium Escherichia coli O157 human oral illness organisms (estimated) [226] not fittable
227 Virus rotavirus rhesus rotavirus vaccine serotype 3 human infants aged 2-5 months oral (w. buffer) seroconversion PFU [227] not yet in wiki
228 Virus rotavirus rhesus rotavirus vaccine serotype 3 human infants aged 2-5 months oral (w/o buffer) seroconversion PFU [228] not yet in wiki
229 Virus rotavirus rhesus rotavirus vaccine serotype 3 human infants aged 2-5 months oral (exclusively breastfed) seroconversion PFU [229] not fittable
230 Virus rotavirus rhesus rotavirus vaccine serotype 3 human infants aged 2-5 months oral (not exclusively breastfed) seroconversion PFU [230] not yet in wiki
231 Bacterium Salmonella anatum strain I human healthy men oral (w. eggnog) positive stool culture organisms [231] fitted
232 Bacterium Salmonella anatum strain II human healthy men oral (w. eggnog) positive stool culture organisms [232] fitted
233 Bacterium Salmonella anatum strain III human healthy men oral (w. eggnog) positive stool culture organisms [233] not yet in wiki
234 Bacterium Salmonella newport human human volunteers oral organisms [234] fitted
235 Bacterium Salmonella derby human human volunteers oral organisms [235] not fittable
236 Bacterium Salmonella bareily human human volunteers oral organisms [236] not fittable
237 Bacterium Salmonella meleagridis strain I human human volunteers oral (w. eggnog) organisms [237] fitted
238 Bacterium Salmonella meleagridis strain II human human volunteers oral (w. eggnog) organisms [238] not fittable
239 Bacterium Salmonella meleagridis strain III human human volunteers oral (w. eggnog) organisms [239] fitted
240 Bacterium Legionella Philadelphia 1 guinea pig inhalation Infection CFU [240] fitted
241 Bacterium Legionella strain 74/81 mice inhalation death CFU [241] fitted
242 Bacterium Legionella Philadelphia 1 guinea pig inhalation death CFU [242] fitted
243 Bacterium Rickettsia rickettsi rhesus macaques aerosol death organisms [243] fitted
244 Bacterium Rickettsia rickettsi KHW mice intravenous infection organisms [244] fitted
245 Bacterium Salmonella nontyphoid strain 216 and 219 mice intraperitoneal death organisms [245] fitted
246 Bacterium Salmonella nontyphoid strain 533 mice intraperitoneal death organisms [246] fitted
247 Bacterium Salmonella nontyphoid strain 533 mice intraperitoneal death organisms [247] fitted
248 Bacterium Vibrio cholerae Inaba 569 B human oral (w. NaHCO3) Infection CFU [248] fitted
249 Prion Prion scrapie strain 263k hamsters oral death LD50 i.c. [249] fitted
250 Prion Prion scrapie strain C506M3 mice intraperitoneal death LD50 i.c. [250] fitted
251 Prion Prion BSE agent mice unknown type of injection Infection ID50 unit [251] fitted
252 Protozoan Naegleria fowleri LEE strain mice intravenous death organism [252] fitted
253 Protozoan Naegleria fowleri LEE strain mice intravenous death organism [253] fitted
254 Virus adenovirus type 4 human intranasal infection TICD50 [254] fitted
255 Virus echovirus 12 human [255] fitted
256 Virus Influenza H1N1,A/California/10/78 attenuated strain human intranasal infection TCID50 [256] fitted
257 Virus Influenza H3N2,A/Washington/897/80 attenuated strain human intranasal infection TCID50 [257] fitted
258 Virus Influenza H5N1, DKGX/35 strain mice intranasal death EID50 [258] fitted
259 Virus SARS rSARS-CoV mice intranasal death PFU [259] fitted
260 Virus SARS MHV-1 mice intranasal death PFU [260] fitted
261 Bacterium Mycobacterium avium sub sp. Paratuberculosis Bovine deer 4 month old red deer oral infection CFU [261] fitted
262 Bacterium Mycobacterium avium sub sp. Paratuberculosis IOI strain cheviots South Country oral infection CFU [262] fitted
263 Protozoan Acanthamoeba Ac118 rat eyes (cornea) infection orgnanism [263] fitted
264 Protozoan Acanthamoeba Ac119 rat eyes (cornea) infection orgnanism [264] fitted
265 Protozoan Acanthamoeba mice intranasal death orgnanism [265] not yet in wiki
266 Protozoan Acanthamoeba guinea pig intracardial death orgnanism [266] not yet in wiki
267 Protozoan Acanthamoeba mice intracerebral death orgnanism [267] not yet in wiki
268 Protozoan Acanthamoeba guinea pig intracerebral death orgnanism [268] not fittable
269 Protozoan Acanthamoeba mice intranasal death orgnanism [269] fitted
270 Protozoan Acanthamoeba mice intranasal brain invasion orgnanism [270] fitted
271 Protozoan Acanthamoeba mice intranasal acute meningoencephalitis orgnanism [271] fitted
272 Protozoan Acanthamoeba mice intranasal Granulotomous Encephalitis orgnanism [272] not fittable
273 Bacterium Francisella tularensis SCHU S-4 monkeys inhalation death organism [273] fitted
274 Bacterium Francisella tularensis Aa strain mice oral death organism [274] fitted
275 Protozoan Naegleria fowleri Lee mice CD 1 intranasal (swimming) death organisms [275] not yet in wiki
276 Protozoan Naegleria fowleri Lee mice CD 1 intranasal (swimming) death organisms [276] not yet in wiki
277 Bacterium Staphylococcus ayreus human subcutaneous infection organisms [277] fitted
278 Bacterium Pseudomonas aeruginosa rabbits contact lens corneal ulceration CFU/ml [278] fitted
279 Bacterium Pseudomonas aeruginosa rabbits contact lens severe stromal ulceration CFU/ml [279] fitted
280 Bacterium Pseudomonas aeruginosa ATCC 19660 mice Swiss -Webster 5 day old injected (eyelids) death CFU [280] fitted
281 Bacterium Pseudomonas aeruginosa ATCC 19660 mice Swiss -Webster 5 day old injected (eyelids) death CFU [281] fitted
282 Bacterium Pseudomonas aeruginosa ATCC 19660 mice Swiss -Webster 10 day old injected (eyelids) death CFU [282] fitted
283 Bacterium Pseudomonas aeruginosa ATCC 19660 mice Swiss -Webster 10 day old injected (eyelids) death CFU [283] fitted
284 Bacterium Pseudomonas aeruginosa ATCC 19660 mice Swiss -Webster 10 day old injected (eyelids) death CFU [284] not yet in wiki
285 Bacterium Pseudomonas aeruginosa ATCC 19660 mice Swiss -Webster 15-16 day old injected (cornea) infection (Keratitis) CFU [285] fitted
286 Bacterium Pseudomonas aeruginosa ATCC 19660 mice Swiss -Webster 21 day old injected (cornea) infection (cataract) CFU [286] not fittable
287 Bacterium Pseudomonas aeruginosa ATCC 19660 mice Swiss -Webster 21 day old injected (cornea) infection (Keratitis) CFU [287] not fittable
288 Bacterium Listeria monocytogenes rhesus monkeys pregnant oral stillbirths CFU [288] fitted
289 Bacterium Listeria monocytogenes mice pregnant oral infected fetuses CFU [289] fitted
290 Bacterium Listeria monocytogenes mice oral death CFU [290] fitted
291 Bacterium Listeria monocytogenes mice oral infection CFU [291] fitted
292 Bacterium Listeria monocytogenes Scott A mice A/J mice intragastric death CFU [292] fitted
293 Bacterium Listeria monocytogenes Scott A mice C57BL/6 intragastric death CFU [293] fitted
294 Bacterium Listeria monocytogenes F5817 mice C57Bl/6J oral infection CFU [294] fitted
295 Bacterium Listeria monocytogenes strain 10401 mice OF1 female oral infection CFU [295] fitted
296 Bacterium Pseudomonas aeruginosa rabbit contact lens corneal ulceration CFU [296] fitted
297 Bacterium Pseudomonas aeruginosa rabbit contact lens Severe stromal ulceration CFU [297] fitted

References

  1. ↑ Lathem WW, Crosby SD, Miller VL and Goldman WE (2005) Progression of primary pneumonic plague: A mouse model of infection, pathology, and bacterial transcriptional activity. Proceedings of the National Academy of Sciences of the United States of America. 102 (49), 17786–17791.
  2. ↑ Parent MA, Berggren KN, Kummer LW, Wilhelm LB, Szaba FM, Mullarky IK and Smiley ST (2005) Cell-Mediated Protection against Pulmonary Yersinia pestis Infection. Infection and Immunity. 73 (11), 7304–7310.
  3. ↑ Rogers JV, Choi YW, Giannunzio LF, Sabourin PJ, Bornman DM, Blosser EG and Sabourin CLK (2007) Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92. Microbial Pathogenesis. 43 (2–3), 67–77.
  4. ↑ Chen TH, Foster LE and Meyer KF (1974) Comparison of the Immune Response to Three Different Yersinia pestis Vaccines in Guinea Pigs and Langurs. Journal of Infectious Diseases. 129 (Supplement 1), S53–S61.
  5. ↑ Chen TH, Foster LE and Meyer KF (1974) Comparison of the Immune Response to Three Different Yersinia pestis Vaccines in Guinea Pigs and Langurs. Journal of Infectious Diseases. 129 (Supplement 1), S53–S61.
  6. ↑ Chen TH, Foster LE and Meyer KF (1974) Comparison of the Immune Response to Three Different Yersinia pestis Vaccines in Guinea Pigs and Langurs. Journal of Infectious Diseases. 129 (Supplement 1), S53–S61.
  7. ↑ SPECK RS and WOLOCHOW H (1957) Studies on the experimental epidemiology of respiratory infections. VIII. Experimental pneumonic plague in Macacus rhesus. The Journal of infectious diseases. 100 (1), 58–69.
  8. ↑ HOLDENRIED R and QUAN SF (1956) Susceptibility of New Mexico rodents to experimental plague. Public health reports. 71 (10), 979–984.
  9. ↑ Marshall RG and Gerone PJ (1961) SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS. Journal of Bacteriology. 82 (1), 15–19.
  10. ↑ Marshall RG and Gerone PJ (1961) SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS. Journal of Bacteriology. 82 (1), 15–19.
  11. ↑ Marshall RG and Gerone PJ (1961) SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS. Journal of Bacteriology. 82 (1), 15–19.
  12. ↑ Marshall RG and Gerone PJ (1961) SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS. Journal of Bacteriology. 82 (1), 15–19.
  13. ↑ Jahrling PB, Smith S, Hesse RA and Rhoderick JB (1982) Pathogenesis of Lassa virus infection in guinea pigs. Infection and Immunity. 37 (2), 771–778.
  14. ↑ Jahrling PB, Smith S, Hesse RA and Rhoderick JB (1982) Pathogenesis of Lassa virus infection in guinea pigs. Infection and Immunity. 37 (2), 771–778.
  15. ↑ Stephenson EH, Larson EW and Dominik JW (1984) Effect of environmental factors on aerosol-induced Lassa virus infection. Journal of medical virology. 14 (4), 295–303.
  16. ↑ Stephenson EH, Larson EW and Dominik JW (1984) Effect of environmental factors on aerosol-induced Lassa virus infection. Journal of medical virology. 14 (4), 295–303.
  17. ↑ Liu B, Koo GC, Yap EH, Chua KL and Gan Y-H (2002) Model of Differential Susceptibility to Mucosal Burkholderia pseudomallei Infection. Infection and Immunity. 70 (2), 504–511.
  18. ↑ Liu B, Koo GC, Yap EH, Chua KL and Gan Y-H (2002) Model of Differential Susceptibility to Mucosal Burkholderia pseudomallei Infection. Infection and Immunity. 70 (2), 504–511.
  19. ↑ Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, Chen D, Lipscomb L, Kim HS, Mrázek J, Nierman WC and DeShazer D (2007) Type VI secretion is a major virulence determinant in Burkholderia mallei. Molecular Microbiology. 64 (6), 1466–1485.
  20. ↑ Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, Chen D, Lipscomb L, Kim HS, Mrázek J, Nierman WC and DeShazer D (2007) Type VI secretion is a major virulence determinant in Burkholderia mallei. Molecular Microbiology. 64 (6), 1466–1485.
  21. ↑ Miller WR, Pannell L, Cravitz L, Tanner WA and Rosebury T (1948) Studies on Certain Biological Characteristics of Malleomyces mallei and Malleomyces pseudomallei. Journal of Bacteriology. 55 (1), 127–135.
  22. ↑ Miller WR, Pannell L, Cravitz L, Tanner WA and Rosebury T (1948) Studies on Certain Biological Characteristics of Malleomyces mallei and Malleomyces pseudomallei. Journal of Bacteriology. 55 (1), 127–135.
  23. ↑ Brett PJ and Woods DE (2000) Pathogenesis of and immunity to melioidosis. Acta Tropica. 74 (2–3), 201–210.
  24. ↑ Russell-Lodrigue KE, Zhang GQ, McMurray DN and Samuel JE (2006) Clinical and Pathologic Changes in a Guinea Pig Aerosol Challenge Model of Acute Q Fever. Infection and Immunity. 74 (11), 6085–6091.
  25. ↑ Andoh M, Naganawa T, Hotta A, Yamaguchi T, Fukushi H, Masegi T and Hirai K (2003) SCID Mouse Model for Lethal Q Fever. Infection and Immunity. 71 (8), 4717–4723.
  26. ↑ Scott GH, Williams JC and Stephenson EH (1987) Animal Models in Q Fever: Pathological Responses of Inbred Mice to Phase I Coxiella burnetii. Journal of General Microbiology. 133 (3), 691–700.
  27. ↑ Scott GH, Williams JC and Stephenson EH (1987) Animal Models in Q Fever: Pathological Responses of Inbred Mice to Phase I Coxiella burnetii. Journal of General Microbiology. 133 (3), 691–700.
  28. ↑ Williams JC and Cantrell JL (1982) Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice. Infection and Immunity. 35 (3), 1091–1102.
  29. ↑ BENENSON AS and TIGERTT WD (1956) Studies on Q fever in man. Transactions of the Association of American Physicians. 69, 98–104.
  30. ↑ Hamory BH, Couch RB, Douglas RG Jr, Black SH and Knight V (1972) Characterization of the infectious unit for man of two respiratory viruses. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 139 (3), 890–893.
  31. ↑ Couch RB, Cate TR, Douglas RG, Gerone PJ and Knight V (1966) Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriological Reviews. 30 (3), 517–529.
  32. ↑ Kurtz JB, Lee TW, Craig JW and Reed SE (1979) Astrovirus infection in volunteers. Journal of medical virology. 3 (3), 221–230.
  33. ↑ Hornick RB, Music SI, Wenzel R, Cash R, Libonati JP, Snyder MJ and Woodward TE (1971) The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bulletin of the New York Academy of Medicine. 47 (10), 1181–1191.
  34. ↑ Hornick RB, Music SI, Wenzel R, Cash R, Libonati JP, Snyder MJ and Woodward TE (1971) The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bulletin of the New York Academy of Medicine. 47 (10), 1181–1191.
  35. ↑ Hornick RB, Music SI, Wenzel R, Cash R, Libonati JP, Snyder MJ and Woodward TE (1971) The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bulletin of the New York Academy of Medicine. 47 (10), 1181–1191.
  36. ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
  37. ↑ Kotak BG, Kenefick SL, Fritz DL, Rousseaux CG, Prepas EE and Hrudey SE (1993) Occurrence and toxicological evaluation of cyanobacterial toxins in Alberta lakes and farm dugouts. Water Research. 27 (3), 495–506.
  38. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  39. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  40. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  41. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  42. ↑ JUNE RC, FERGUSON WW and WORFEL MT (1953) Experiments in feeding adult volunteers with Escherichia coli 55, B5, a coliform organism associated with infant diarrhea. American journal of hygiene. 57 (2), 222–236.
  43. ↑ Feeguson WW and June EC (1952) Experiments on Feeding Adult Volunteers with Escherichia Coli 111, B4, a Coliform Organism Associated with Infant Diarrhea. American Journal of Epidemiology. 55 (2), 155–160.
  44. ↑ Haas CN, Rose JB and Gerba CP (1999) Quantitative Microbial Risk Assessment. John Wiley and Sons
  45. ↑ RENDTORFF RC (1954) The experimental transmission of human intestinal protozoan parasites. I. Endamoeba coli cysts given in capsules. American journal of hygiene. 59 (2), 196–208.
  46. ↑ RENDTORFF RC (1954) The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. American journal of hygiene. 59 (2), 209–220.
  47. ↑ Erlandsen SL, Sherlock LA, Januschka M, Schupp DG, Schaefer FW, Jakubowski W and Bemrick WJ (1988) Cross-species transmission of Giardia spp.: inoculation of beavers and muskrats with cysts of human, beaver, mouse, and muskrat origin. Applied and Environmental Microbiology. 54 (11), 2777–2785.
  48. ↑ Erlandsen SL, Sherlock LA, Januschka M, Schupp DG, Schaefer FW, Jakubowski W and Bemrick WJ (1988) Cross-species transmission of Giardia spp.: inoculation of beavers and muskrats with cysts of human, beaver, mouse, and muskrat origin. Applied and Environmental Microbiology. 54 (11), 2777–2785.
  49. ↑ Istre GR, Dunlop TS, Gaspard GB and Hopkins RS (1984) Waterborne giardiasis at a mountain resort: evidence for acquired immunity. American Journal of Public Health. 74 (6), 602–604.
  50. ↑ Labatiuk CW, Schaefer FW, Finch GR and Belosevic M (1991) Comparison of animal infectivity, excystation, and fluorogenic dye as measures of Giardia muris cyst inactivation by ozone. Applied and Environmental Microbiology. 57 (11), 3187–3192.
  51. ↑ WARD R, KRUGMAN S, GILES JP, JACOBS AM and BODANSKY O (1958) Infectious hepatitis; studies of its natural history and prevention. The New England journal of medicine. 258 (9), 407–416.
  52. ↑ WARD R, KRUGMAN S, GILES JP, JACOBS AM and BODANSKY O (1958) Infectious hepatitis; studies of its natural history and prevention. The New England journal of medicine. 258 (9), 407–416.
  53. ↑ Taylor-Robinson D and Bynoe ML (1963) Para-influenza 2 virus infections in adult volunteers. The Journal of Hygiene. 61 (4), 407–417.
  54. ↑ Taylor-Robinson D and Bynoe ML (1963) Para-influenza 2 virus infections in adult volunteers. The Journal of Hygiene. 61 (4), 407–417.
  55. ↑ CRAIGHEAD JE, COOK MK and CHANOCK RM (1960) Infection of hamsters with para influenza 3 virus. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 104, 301–304.
  56. ↑ Koprowski H (1956) Immunization against Poliomyelitis with Living Attenuated Virus. The American Journal of Tropical Medicine and Hygiene. 5 (3), 440–452.
  57. ↑ Minor TE, Allen CI, Tsiatis AA, Nelson DB and D’Alessio DJ (1981) Human infective dose determinations for oral poliovirus type 1 vaccine in infants. Journal of Clinical Microbiology. 13 (2), 388–389.
  58. ↑ Koprowski H (1956) Immunization against Poliomyelitis with Living Attenuated Virus. The American Journal of Tropical Medicine and Hygiene. 5 (3), 440–452.
  59. ↑ SABIN AB (1955) Behavior of chimpanzee avirulent poliomyelitis viruses in experimentally infected human volunteers. The American journal of the medical sciences. 230 (1), 1–8.
  60. ↑ Katz M and Plotkin SA (1967) Minimal infective dose of attenuated poliovirus for man. American Journal of Public Health and the Nations Health. 57 (10), 1837–1840.
  61. ↑ SABIN AB (1955) Behavior of chimpanzee avirulent poliomyelitis viruses in experimentally infected human volunteers. The American journal of the medical sciences. 230 (1), 1–8.
  62. ↑ Cliver, D. O. (1981). Experimental infection by waterborne enteroviruses. Journal of Food Protection. 44,861-865.
  63. ↑ Cliver, D. O. (1981). Experimental infection by waterborne enteroviruses. Journal of Food Protection. 44,861-865.
  64. ↑ Hendley JO, Edmondson WP and Gwaltney JM (1972) Relation between Naturally Acquired Immunity and Infectivity of Two Rhinoviruses in Volunteers. Journal of Infectious Diseases. 125 (3), 243–248.
  65. ↑ Hendley JO, Edmondson WP and Gwaltney JM (1972) Relation between Naturally Acquired Immunity and Infectivity of Two Rhinoviruses in Volunteers. Journal of Infectious Diseases. 125 (3), 243–248.
  66. ↑ Graham DY, Dufour GR and Estes MK (1987) Minimal infective dose of rotavirus. Archives of virology. 92 (3-4), 261–271.
  67. ↑ Gouvea VS, Alencar AA, Barth OM, Castro L de, Fialho AM, Araújo HP, Majerowicz S and Pereira HG (1986) Diarrhoea in Mice Infected with a Human Rotavirus. Journal of General Virology. 67 (3), 577–581.
  68. ↑ Payment P and Morin E (1990) Minimal infective dose of the OSU strain of porcine rotavirus. Archives of virology. 112 (3-4), 277–282.
  69. ↑ Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR and Schiff GM (1986) Human Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection. Journal of Infectious Diseases. 154 (5), 871–880.
  70. ↑ Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR and Schiff GM (1986) Human Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection. Journal of Infectious Diseases. 154 (5), 871–880.
  71. ↑ Hall CB, Douglas RG, Schnabel KC and Geiman JM (1981) Infectivity of respiratory syncytial virus by various routes of inoculation. Infection and Immunity. 33 (3), 779–783.
  72. ↑ Hall CB, Douglas RG, Schnabel KC and Geiman JM (1981) Infectivity of respiratory syncytial virus by various routes of inoculation. Infection and Immunity. 33 (3), 779–783.
  73. ↑ Hall CB, Douglas RG, Schnabel KC and Geiman JM (1981) Infectivity of respiratory syncytial virus by various routes of inoculation. Infection and Immunity. 33 (3), 779–783.
  74. ↑ Parrott RH, Kim HW, Brandt CD and Chanock RM (1974) Respiratory syncytial virus in infants and children. Preventive medicine. 3 (4), 473–480.
  75. ↑ Wright PF, Belshe RB, Kim HW, Van Voris LP and Chanock RM (1982) Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infection and Immunity. 37 (1), 397–400.
  76. ↑ Plotkin SA, Cornfeld D and Ingalls TH (1965) Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus. American journal of diseases of children (1960). 110 (4), 381–389.
  77. ↑ Feldman RE, Baine WB, Nitzkin JL, Saslaw MS and Pollard RA (1974) Epidemiology of Salmonella typhi Infection in a Migrant Labor Camp in Dade County, Florida. Journal of Infectious Diseases. 130 (4), 334–342.
  78. ↑ Hornick RB, Woodward TE, McCrumb FR, Snyder MJ, Dawkins AT, Bulkeley JT, De la Macorra F and Corozza FA (1966) Study of induced typhoid fever in man. I. Evaluation of vaccine effectiveness. Transactions of the Association of American Physicians. 79, 361–367.
  79. ↑ Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT and Snyder MJ (1970) Typhoid fever: pathogenesis and immunologic control. The New England journal of medicine. 283 (13), 686–691.
  80. ↑ Levine MM, DuPont HL, Formal SB, Hornick RB, Takeuchi A, Gangarosa EJ, Snyder MJ and Libonati JP (1973) Pathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery. Journal of Infectious Diseases. 127 (3), 261–270.
  81. ↑ DuPont HL, Hornick RB, Dawkins AT, Snyder MJ and Formal SB (1969) The Response of Man to Virulent Shigella flexneri 2a. Journal of Infectious Diseases. 119 (3), 296–299.
  82. ↑ DuPont HL, Hornick RB, Snyder MJ, Libonati JP, Formal SB and Gangarosa EJ (1972) Immunity in Shigellosis. I. Response of Man to Attenuated Strains of Shigella. Journal of Infectious Diseases. 125 (1), 5–11.
  83. ↑ Altboum Z, Gozes Y, Barnea A, Pass A, White M and Kobiler D (2002) Postexposure Prophylaxis against Anthrax: Evaluation of Various Treatment Regimens in Intranasally Infected Guinea Pigs. Infection and Immunity. 70 (11), 6231–6241.
  84. ↑ Altboum Z, Gozes Y, Barnea A, Pass A, White M and Kobiler D (2002) Postexposure Prophylaxis against Anthrax: Evaluation of Various Treatment Regimens in Intranasally Infected Guinea Pigs. Infection and Immunity. 70 (11), 6231–6241.
  85. ↑ Druett HA, Henderson DW, Packman L and Peacock S (1953) Studies on respiratory infection. The Journal of Hygiene. 51 (3), 359–371.
  86. ↑ Druett HA, Henderson DW, Packman L and Peacock S (1953) Studies on respiratory infection. The Journal of Hygiene. 51 (3), 359–371.
  87. ↑ JUNE RC, FERGUSON WW and WORFEL MT (1953) Experiments in feeding adult volunteers with Escherichia coli 55, B5, a coliform organism associated with infant diarrhea. American journal of hygiene. 57 (2), 222–236.
  88. ↑ Feeguson WW and June EC (1952) Experiments on Feeding Adult Volunteers with Escherichia Coli 111, B4, a Coliform Organism Associated with Infant Diarrhea. American Journal of Epidemiology. 55 (2), 155–160.
  89. ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
  90. ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
  91. ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
  92. ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
  93. ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
  94. ↑ Morgan DR, Johnson PC, DuPont HL, Satterwhite TK and Wood LV (1985) Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infection and Immunity. 50 (1), 62–65.
  95. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  96. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  97. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  98. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  99. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  100. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  101. ↑ DuPont HL, Formal SB, Hornick RB, Snyder MJ, Libonati JP, Sheahan DG, LaBrec EH and Kalas JP (1971) Pathogenesis of Escherichia coli diarrhea. The New England journal of medicine. 285 (1), 1–9.
  102. ↑ Buck AC and Cooke EM (1969) The Fate Of Ingested Pseudomonas Aeruginosa In Normal Persons. Journal of Medical Microbiology. 2 (4), 521–525.
  103. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  104. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  105. ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
  106. ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
  107. ↑ DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB and Jakubowski W (1995) The infectivity of Cryptosporidium parvum in healthy volunteers. The New England journal of medicine. 332 (13), 855–859.
  108. ↑ DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB and Jakubowski W (1995) The infectivity of Cryptosporidium parvum in healthy volunteers. The New England journal of medicine. 332 (13), 855–859.
  109. ↑ LEPOW ML, WARREN RJ, INGRAM VG, DAUGHERTY SC and ROBBINS FC (1962) Sabin type I (LSc2ab) oral poliomyelitis vaccine. Effect of dose upon response of newborn infants. American journal of diseases of children (1960). 104, 67–71.
  110. ↑ Katz M and Plotkin SA (1967) Minimal infective dose of attenuated poliovirus for man. American Journal of Public Health and the Nations Health. 57 (10), 1837–1840.
  111. ↑ Schiff GM, Stefanović GM, Young EC, Sander DS, Pennekamp JK and Ward RL (1984) Studies of echovirus-12 in volunteers: determination of minimal infectious dose and the effect of previous infection on infectious dose. The Journal of infectious diseases. 150 (6), 858–866.
  112. ↑ Suptel, E.A. (1963) Pathogenesis of experimental Coxsackie virus infection. Archive of Virology. 7, 61-66
  113. ↑ Couch RB, Cate TR, Gerone PJ, Fleet WF, Lang DJ, Griffith WR and Knight V (1965) Production of Illness with a Small-Particle Aerosol of Coxsackie A21*. Journal of Clinical Investigation. 44 (4), 535–542.
  114. ↑ Couch RB, Cate TR, Gerone PJ, Fleet WF, Lang DJ, Griffith WR and Knight V (1965) Production of Illness with a Small-Particle Aerosol of Coxsackie A21*. Journal of Clinical Investigation. 44 (4), 535–542.
  115. ↑ Couch RB, Cate TR, Gerone PJ, Fleet WF, Lang DJ, Griffith WR and Knight V (1965) Production of Illness with a Small-Particle Aerosol of Coxsackie A21*. Journal of Clinical Investigation. 44 (4), 535–542.
  116. ↑ Couch RB, Cate TR, Gerone PJ, Fleet WF, Lang DJ, Griffith WR and Knight V (1965) Production of Illness with a Small-Particle Aerosol of Coxsackie A21*. Journal of Clinical Investigation. 44 (4), 535–542.
  117. ↑ Couch RB, Knight V, Gerone PJ, Cate TR and Douglas RG (1969) Factors influencing response of volunteers to inoculation with Coxsackie virus A type 21. The American review of respiratory disease. 99 (1), 24–30.
  118. ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
  119. ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
  120. ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
  121. ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
  122. ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
  123. ↑ Spickard A, Evans H, Knight V and Johnson K (1963) ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42 (6), 840–852.
  124. ↑ Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR and Schiff GM (1986) Human Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection. Journal of Infectious Diseases. 154 (5), 871–880.
  125. ↑ Kotak BG, Kenefick SL, Fritz DL, Rousseaux CG, Prepas EE and Hrudey SE (1993) Occurrence and toxicological evaluation of cyanobacterial toxins in Alberta lakes and farm dugouts. Water Research. 27 (3), 495–506.
  126. ↑ Kotak BG, Kenefick SL, Fritz DL, Rousseaux CG, Prepas EE and Hrudey SE (1993) Occurrence and toxicological evaluation of cyanobacterial toxins in Alberta lakes and farm dugouts. Water Research. 27 (3), 495–506.
  127. ↑ Kotak BG, Kenefick SL, Fritz DL, Rousseaux CG, Prepas EE and Hrudey SE (1993) Occurrence and toxicological evaluation of cyanobacterial toxins in Alberta lakes and farm dugouts. Water Research. 27 (3), 495–506.
  128. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  129. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  130. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  131. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  132. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  133. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  134. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  135. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  136. ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
  137. ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
  138. ↑ Messner MJ, Chappell CL and Okhuysen PC (2001) Risk Assessment for Cryptosporidium: A Hierarchical Bayesian Analysis of Human Dose Response Data. Water Research. 35 (16), 3934–3940.
  139. ↑ Messner MJ, Chappell CL and Okhuysen PC (2001) Risk Assessment for Cryptosporidium: A Hierarchical Bayesian Analysis of Human Dose Response Data. Water Research. 35 (16), 3934–3940.
  140. ↑ Messner MJ, Chappell CL and Okhuysen PC (2001) Risk Assessment for Cryptosporidium: A Hierarchical Bayesian Analysis of Human Dose Response Data. Water Research. 35 (16), 3934–3940.
  141. ↑ Coster TS, Wolf MK, Hall ER, Cassels FJ, Taylor DN, Liu CT, Trespalacios FC, DeLorimier A, Angleberger DR and McQueen CE (2007) Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infection and immunity. 75 (1), 252–259.
  142. ↑ Coster TS, Wolf MK, Hall ER, Cassels FJ, Taylor DN, Liu CT, Trespalacios FC, DeLorimier A, Angleberger DR and McQueen CE (2007) Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infection and immunity. 75 (1), 252–259.
  143. ↑ Graham DY, Estes MK and Gentry LO (1983) Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers. Gastroenterology. 85 (5), 1017–1022.
  144. ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
  145. ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
  146. ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
  147. ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
  148. ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
  149. ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
  150. ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
  151. ↑ Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB and Young CR (1979) Immunity to Enterotoxigenic Escherichia coli. Infection and Immunity. 23 (3), 729–736.
  152. ↑ Tacket CO, Sztein MB, Losonsky G, Abe A, Finlay BB, McNamara BP, Fantry GT, James SP, Nataro JP, Levine MM and Donnenberg MS (2000) Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68 (6), 3689–3695.
  153. ↑ Tacket CO, Sztein MB, Losonsky G, Abe A, Finlay BB, McNamara BP, Fantry GT, James SP, Nataro JP, Levine MM and Donnenberg MS (2000) Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68 (6), 3689–3695.
  154. ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
  155. ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
  156. ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
  157. ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
  158. ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
  159. ↑ Donnenberg MS, Tacket CO, James SP, Losonsky G, Nataro JP, Wasserman SS, Kaper JB and Levine MM (1993) Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92 (3), 1412–1417.
  160. ↑ Clements ML, Levine MM, Black RE, Robins-Browne RM, Cisneros LA, Drusano GL, Lanata CF and Saah AJ (1981) Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrobial Agents and Chemotherapy. 20 (1), 104–108.
  161. ↑ Clements ML, Levine MM, Black RE, Robins-Browne RM, Cisneros LA, Drusano GL, Lanata CF and Saah AJ (1981) Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrobial Agents and Chemotherapy. 20 (1), 104–108.
  162. ↑ Clements ML, Levine MM, Black RE, Robins-Browne RM, Cisneros LA, Drusano GL, Lanata CF and Saah AJ (1981) Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrobial Agents and Chemotherapy. 20 (1), 104–108.
  163. ↑ Clements ML, Levine MM, Black RE, Robins-Browne RM, Cisneros LA, Drusano GL, Lanata CF and Saah AJ (1981) Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrobial Agents and Chemotherapy. 20 (1), 104–108.
  164. ↑ Levine MM, Caplan ES, Waterman D, Cash RA, Hornick RB and Snyder MJ (1977) Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infection and Immunity. 17 (1), 78–82.
  165. ↑ Levine MM, Caplan ES, Waterman D, Cash RA, Hornick RB and Snyder MJ (1977) Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infection and Immunity. 17 (1), 78–82.
  166. ↑ Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP and Hornick RB (1974) Response of Man to Infection with Vibrio cholerae. I. Clinical, Serologic, and Bacteriologic Responses to a Known Inoculum. The Journal of Infectious Diseases. 129 (1), 45–52.
  167. ↑ Levine MM, Black RE, Brinton CC Jr, Clements ML, Fusco P, Hughes TP, O’Donnell S, Robins-Browne R, Wood S and Young CR (1982) Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scandinavian journal of infectious diseases. Supplementum. 33, 83–95.
  168. ↑ Levine MM, Black RE, Brinton CC Jr, Clements ML, Fusco P, Hughes TP, O’Donnell S, Robins-Browne R, Wood S and Young CR (1982) Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scandinavian journal of infectious diseases. Supplementum. 33, 83–95.
  169. ↑ Levine MM, Rennels MB, Cisneros L, Hughes TP, Nalin DR and Young CR (1980) Lack of Person-to-Person Transmission of Enterotoxigenic Escherichia Coli Despite Close Contact. American Journal of Epidemiology. 111 (3), 347–355.
  170. ↑ Levine MM, Rennels MB, Cisneros L, Hughes TP, Nalin DR and Young CR (1980) Lack of Person-to-Person Transmission of Enterotoxigenic Escherichia Coli Despite Close Contact. American Journal of Epidemiology. 111 (3), 347–355.
  171. ↑ Levine MM, Rennels MB, Cisneros L, Hughes TP, Nalin DR and Young CR (1980) Lack of Person-to-Person Transmission of Enterotoxigenic Escherichia Coli Despite Close Contact. American Journal of Epidemiology. 111 (3), 347–355.
  172. ↑ Teunis PFM, Moe CL, Liu P, E. Miller S, Lindesmith L, Baric RS, Le Pendu J and Calderon RL (2008) Norwalk virus: How infectious is it? Journal of Medical Virology. 80 (8), 1468–1476.
  173. ↑ Teunis PFM, Moe CL, Liu P, E. Miller S, Lindesmith L, Baric RS, Le Pendu J and Calderon RL (2008) Norwalk virus: How infectious is it? Journal of Medical Virology. 80 (8), 1468–1476.
  174. ↑ Teunis PFM, Moe CL, Liu P, E. Miller S, Lindesmith L, Baric RS, Le Pendu J and Calderon RL (2008) Norwalk virus: How infectious is it? Journal of Medical Virology. 80 (8), 1468–1476.
  175. ↑ Teunis PFM, Moe CL, Liu P, E. Miller S, Lindesmith L, Baric RS, Le Pendu J and Calderon RL (2008) Norwalk virus: How infectious is it? Journal of Medical Virology. 80 (8), 1468–1476.
  176. ↑ Pai CH, Kelly JK and Meyers GL (1986) Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infection and Immunity. 51 (1), 16–23.
  177. ↑ Pai CH, Kelly JK and Meyers GL (1986) Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infection and Immunity. 51 (1), 16–23.
  178. ↑ Pai CH, Kelly JK and Meyers GL (1986) Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infection and Immunity. 51 (1), 16–23.
  179. ↑ Chappell CL, Okhuysen PC, Langer-Curry R, Widmer G, Akiyoshi DE, Tanriverdi S and Tzipori S (2006) Cryptosporidium Hominis: Experimental Challenge of Healthy Adults. The American Journal of Tropical Medicine and Hygiene. 75 (5), 851–857.
  180. ↑ Chappell CL, Okhuysen PC, Langer-Curry R, Widmer G, Akiyoshi DE, Tanriverdi S and Tzipori S (2006) Cryptosporidium Hominis: Experimental Challenge of Healthy Adults. The American Journal of Tropical Medicine and Hygiene. 75 (5), 851–857.
  181. ↑ Okhuysen PC, Rich SM, Chappell CL, Grimes KA, Widmer G, Feng X and Tzipori S (2002) Infectivity of a Cryptosporidium parvum Isolate of Cervine Origin for Healthy Adults and Interferon-γ Knockout Mice. Journal of Infectious Diseases. 185 (9), 1320–1325.
  182. ↑ Okhuysen PC, Rich SM, Chappell CL, Grimes KA, Widmer G, Feng X and Tzipori S (2002) Infectivity of a Cryptosporidium parvum Isolate of Cervine Origin for Healthy Adults and Interferon-γ Knockout Mice. Journal of Infectious Diseases. 185 (9), 1320–1325.
  183. ↑ Blaser MJ, Duncan DJ, Warren GH and Wang W-LL (1983) Experimental Campylobacter jejuni Infection of Adult Mice. Infection and Immunity. 39 (2), 908–916.
  184. ↑ Blaser MJ, Duncan DJ, Warren GH and Wang W-LL (1983) Experimental Campylobacter jejuni Infection of Adult Mice. Infection and Immunity. 39 (2), 908–916.
  185. ↑ Blaser MJ, Duncan DJ, Warren GH and Wang W-LL (1983) Experimental Campylobacter jejuni Infection of Adult Mice. Infection and Immunity. 39 (2), 908–916.
  186. ↑ Tribble DR, Baqar S, Carmolli MP, Porter C, Pierce KK, Sadigh K, Guerry P, Larsson CJ, Rockabrand D, Ventone CH, Poly F, Lyon CE, Dakdouk S, Fingar A, Gilliland T, Daunais P, Jones E, Rymarchyk S, Huston C, Darsley M and Kirkpatrick BD (2009) Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49 (10), 1512–1519.
  187. ↑ Tribble DR, Baqar S, Scott DA, Oplinger ML, Trespalacios F, Rollins D, Walker RI, Clements JD, Walz S, Gibbs P, Burg EF, Moran AP, Applebee L and Bourgeois AL (2010) Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans. Infection and Immunity. 78 (4), 1750–1759.
  188. ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
  189. ↑ Black RE, Levine MM, Clements ML, Hughes TP and Blaser MJ (1988) Experimental Campylobacter jejuni Infection in Humans. Journal of Infectious Diseases. 157 (3), 472–479.
  190. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  191. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  192. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  193. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  194. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  195. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  196. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  197. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  198. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  199. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  200. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  201. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  202. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  203. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  204. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  205. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  206. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  207. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  208. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  209. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  210. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  211. ↑ Chen L, Geys H, Cawthraw S, Havelaar A and Teunis P (2006) Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26 (6), 1613–1621.
  212. ↑ Cornick NA and Helgerson AF (2004) Transmission and Infectious Dose of Escherichia coli O157:H7 in Swine. Applied and Environmental Microbiology. 70 (9), 5331–5335.
  213. ↑ Bieber D, Ramer SW, Wu C-Y, Murray WJ, Tobe T, Fernandez R and Schoolnik GK (1998) Type IV Pili, Transient Bacterial Aggregates, and Virulence of Enteropathogenic Escherichia coli. Science. 280 (5372), 2114–2118.
  214. ↑ Levine MM, DuPont HL, Formal SB, Hornick RB, Takeuchi A, Gangarosa EJ, Snyder MJ and Libonati JP (1973) Pathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery. Journal of Infectious Diseases. 127 (3), 261–270.
  215. ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
  216. ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
  217. ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
  218. ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
  219. ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
  220. ↑ Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR and Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1 (8074), 1119–1122.
  221. ↑ Black RE, Brown KH, Becker S, Alim ARMA and Huq I (1982) Longitudinal Studies of Infectious Diseases and Physical Growth of Children in Rural Bangladesh Ii. Incidence of Diarrhea and Association with Known Pathogens. American Journal of Epidemiology. 115 (3), 315–324.
  222. ↑ Bartrand TA, Weir MH and Haas CN (2008) Dose-Response Models for Inhalation of Bacillus anthracis Spores: Interspecies Comparisons. Risk Analysis. 28 (4), 1115–1124.
  223. ↑ DuPont HL, Levine MM, Hornick RB and Formal SB (1989) Inoculum Size in Shigellosis and Implications for Expected Mode of Transmission. Journal of Infectious Diseases. 159 (6), 1126–1128.
  224. ↑ DuPont HL, Levine MM, Hornick RB and Formal SB (1989) Inoculum Size in Shigellosis and Implications for Expected Mode of Transmission. Journal of Infectious Diseases. 159 (6), 1126–1128.
  225. ↑ DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB and Jakubowski W (1995) The infectivity of Cryptosporidium parvum in healthy volunteers. The New England journal of medicine. 332 (13), 855–859.
  226. ↑ Strachan NJC, Doyle MP, Kasuga F, Rotariu O and Ogden ID (2005) Dose response modelling of Escherichia coli O157 incorporating data from foodborne and environmental outbreaks. International Journal of Food Microbiology. 103 (1), 35–47.
  227. ↑ Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A and Dolin R (1988) Field trial of rhesus rotavirus vaccine in infants. The Pediatric infectious disease journal. 7 (9), 645–650.
  228. ↑ Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A and Dolin R (1988) Field trial of rhesus rotavirus vaccine in infants. The Pediatric infectious disease journal. 7 (9), 645–650.
  229. ↑ Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A and Dolin R (1988) Field trial of rhesus rotavirus vaccine in infants. The Pediatric infectious disease journal. 7 (9), 645–650.
  230. ↑ Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A and Dolin R (1988) Field trial of rhesus rotavirus vaccine in infants. The Pediatric infectious disease journal. 7 (9), 645–650.
  231. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  232. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  233. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  234. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  235. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  236. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  237. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  238. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  239. ↑ McCullough NB and Elsele CW (1951) Experimental Human Salmonellosis: I. Pathogenicity of Strains of Salmonella meleagridis and Salmonella anatum Obtained from Spray-Dried Whole Egg. The Journal of Infectious Diseases. 88 (3), 278–289.
  240. ↑ Muller D, Edwards ML and Smith DW (1983) Changes in Iron and Transferrin Levels and Body Temperature in Experimental Airborne Legionellosis. The Journal of Infectious Diseases. 147 (2), 302–307.
  241. ↑ Fitzgeorge RB, Baskerville A, Broster M, Hambleton P and Dennis PJ (1983) Aerosol infection of animals with strains of Legionella pneumophila of different virulence: comparison with intraperitoneal and intranasal routes of infection. Epidemiology & Infection. 90 (01), 81–89.
  242. ↑ Breiman RF and Horwitz MA (1987) Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens. The Journal of Experimental Medicine. 165 (3), 799–811.
  243. ↑ Saslaw S and Carlisle HN (1966) Aerosol infection of monkeys with Rickettsia rickettsii. Bacteriological Reviews. 30 (3), 636–645.
  244. ↑ Sammons LS, Kenyon RH and Pedersen CE (1976) Effect of vaccination schedule on immune response of Macaca mulatta to cell culture-grown Rocky Mountain spotted fever vaccine. Journal of Clinical Microbiology. 4 (3), 253–257.
  245. ↑ Meynell GG and Meynell EW (1958) The growth of micro-organisms in vivo with particular reference to the relation between dose and latent period. Epidemiology & Infection. 56 (03), 323–346.
  246. ↑ Meynell GG and Meynell EW (1958) The growth of micro-organisms in vivo with particular reference to the relation between dose and latent period. Epidemiology & Infection. 56 (03), 323–346.
  247. ↑ Meynell GG and Meynell EW (1958) The growth of micro-organisms in vivo with particular reference to the relation between dose and latent period. Epidemiology & Infection. 56 (03), 323–346.
  248. ↑ Hornick RB, Music SI, Wenzel R, Cash R, Libonati JP, Snyder MJ and Woodward TE (1971) The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bulletin of the New York Academy of Medicine. 47 (10), 1181–1191.
  249. ↑ Diringer H, Roehmel J and Beekes M (1998) Effect of repeated oral infection of hamsters with scrapie. Journal of General Virology. 79 (3), 609–612.
  250. ↑ Jacquemot C, Cuche C, Dormont D and Lazarini F (2005) High Incidence of Scrapie Induced by Repeated Injections of Subinfectious Prion Doses. Journal of Virology. 79 (14), 8904–8908.
  251. ↑ Taylor DM, Woodgate SL and Atkinson MJ (1995) Inactivation of the bovine spongiform encephalopathy agent by rendering procedures. Veterinary Record. 137 (24), 605–610.
  252. ↑ John DT and Hoppe KL (1990) Susceptibility of Wild Mammals to Infection with Naegleria fowleri. The Journal of Parasitology. 76 (6), 865–868.
  253. ↑ John DT and Hoppe KL (1990) Susceptibility of Wild Mammals to Infection with Naegleria fowleri. The Journal of Parasitology. 76 (6), 865–868.
  254. ↑ Couch RB, Cate TR, Douglas RG, Gerone PJ and Knight V (1966) Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriological Reviews. 30 (3), 517–529.
  255. ↑ Schiff GM, Stefanović GM, Young EC, Sander DS, Pennekamp JK and Ward RL (1984) Studies of echovirus-12 in volunteers: determination of minimal infectious dose and the effect of previous infection on infectious dose. The Journal of infectious diseases. 150 (6), 858–866.
  256. ↑ Murphy BR, Clements ML, Madore HP, Steinberg J, O’Donnell S, Betts R, Demico D, Reichman RC, Dolin R and Maassab HF (1984) Dose Response of Cold-Adapted, Reassortant Influenza A/California/10/78 Virus (H1N1) in Adult Volunteers. Journal of Infectious Diseases. 149 (5), 816–816.
  257. ↑ Murphy BR, Clements ML, Tierney EL, Black RE, Stienberg J and Chanock RM (1985) Dose Response of Influenza A/Washington/897/80 (H3N2) Avian-Human Reassortant Virus in Adult Volunteers. The Journal of Infectious Diseases. 152 (1), 225–229.
  258. ↑ Fan S, Deng G, Song J, Tian G, Suo Y, Jiang Y, Guan Y, Bu Z, Kawaoka Y and Chen H (2009) Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology. 384 (1), 28–32.
  259. ↑ DeDiego ML, Pewe L, Alvarez E, Rejas MT, Perlman S and Enjuanes L (2008) Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice. Virology. 376 (2), 379–389.
  260. ↑ Albuquerque ND, Baig E, Ma X, Zhang J, He W, Rowe A, Habal M, Liu M, Shalev I, Downey GP, Gorczynski R, Butany J, Leibowitz J, Weiss SR, McGilvray ID, Phillips MJ, Fish EN and Levy GA (2006) Murine Hepatitis Virus Strain 1 Produces a Clinically Relevant Model of Severe Acute Respiratory Syndrome in A/J Mice. Journal of Virology. 80 (21), 10382–10394.
  261. ↑ O’Brien R, Mackintosh CG, Bakker D, Kopecna M, Pavlik I and Griffin JFT (2006) Immunological and Molecular Characterization of Susceptibility in Relationship to Bacterial Strain Differences in Mycobacterium avium subsp. paratuberculosis Infection in the Red Deer (Cervus elaphus). Infection and Immunity. 74 (6), 3530–3537.
  262. ↑ NISBET DI, GILMOUR NJ and BROTHERSTON JG (1962) Quantitative studies of Mycobacterium johnei in tissues of sheep. III. Intestinal histopathology. Journal of comparative pathology. 72, 80–91.
  263. ↑ Badenoch PR, Johnson AM, Christy PE and Coster DJ (1990) Pathogenicity of Acanthamoeba and a Corynebacterium in the Rat Cornea. Archives of Ophthalmology. 108 (1), 107–112.
  264. ↑ Badenoch PR, Johnson AM, Christy PE and Coster DJ (1990) Pathogenicity of Acanthamoeba and a Corynebacterium in the Rat Cornea. Archives of Ophthalmology. 108 (1), 107–112.
  265. ↑ Cerva L (1967-2) Intracerebral Inoculation of Experimental Animals in Pathogenetical Studies of Hartmannella Castellanii . Folia Parastologica. 14,171-176
  266. ↑ Cerva L (1967-2) Intracerebral Inoculation of Experimental Animals in Pathogenetical Studies of Hartmannella Castellanii . Folia Parastologica. 14,171-176
  267. ↑ Cerva L (1967-2) Intracerebral Inoculation of Experimental Animals in Pathogenetical Studies of Hartmannella Castellanii . Folia Parastologica. 14,171-176
  268. ↑ Cerva L (1967-2) Intracerebral Inoculation of Experimental Animals in Pathogenetical Studies of Hartmannella Castellanii . Folia Parastologica. 14,171-176
  269. ↑ Culbertson CG, Ensminger PW and Overton WM (1966) Hartmannella (acanthamoeba). Experimental chronic, granulomatous brain infections produced by new isolates of low virulence. American journal of clinical pathology. 46 (3), 305–314.
  270. ↑ Culbertson CG, Ensminger PW and Overton WM (1966) Hartmannella (acanthamoeba). Experimental chronic, granulomatous brain infections produced by new isolates of low virulence. American journal of clinical pathology. 46 (3), 305–314.
  271. ↑ Culbertson CG, Ensminger PW and Overton WM (1966) Hartmannella (acanthamoeba). Experimental chronic, granulomatous brain infections produced by new isolates of low virulence. American journal of clinical pathology. 46 (3), 305–314.
  272. ↑ Culbertson CG, Ensminger PW and Overton WM (1966) Hartmannella (acanthamoeba). Experimental chronic, granulomatous brain infections produced by new isolates of low virulence. American journal of clinical pathology. 46 (3), 305–314.
  273. ↑ Day WC and Berendt RF (1972) Experimental Tularemia in Macaca mulatta: Relationship of Aerosol Particle Size to the Infectivity of Airborne Pasteurella tularensis. Infection and Immunity. 5 (1), 77–82.
  274. ↑ Quan SF, McManus AG and H. von Fintel (1956) Infectivity of Tularemia Applied to Intact Skin and Ingested in Drinking Water. Science. 123 (3204), 942–943.
  275. ↑ John DT and Hoppe KL (1990) Susceptibility of Wild Mammals to Infection with Naegleria fowleri. The Journal of Parasitology. 76 (6), 865–868.
  276. ↑ John DT and Hoppe KL (1990) Susceptibility of Wild Mammals to Infection with Naegleria fowleri. The Journal of Parasitology. 76 (6), 865–868.
  277. ↑ Rose JB and Haas CN (1999) A risk assessment framework for the evaluation of skin infections and the potential impact of antibacterial soap washing. American Journal of Infection Control. 27 (6), S26–S33.
  278. ↑ Lawin-Brüssel CA, Refojo MF, Leong FL, Hanninen L and Kenyon KR (1993) Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea. 12 (1), 10–18.
  279. ↑ Lawin-Brüssel CA, Refojo MF, Leong FL, Hanninen L and Kenyon KR (1993) Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea. 12 (1), 10–18.
  280. ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
  281. ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
  282. ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
  283. ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
  284. ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
  285. ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
  286. ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
  287. ↑ Hazlett LD, Rosen DD and Berk RS (1978) Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20 (1), 25–29.
  288. ↑ Smith MA, Takeuchi K, Anderson G, Ware GO, McClure HM, Raybourne RB, Mytle N and Doyle MP (2008) Dose-Response Model for Listeria monocytogenes-Induced Stillbirths in Nonhuman Primates. Infection and Immunity. 76 (2), 726–731.
  289. ↑ Williams D, Irvin EA, Chmielewski RA and Frank JF (May) Dose-Response of Listeria monocytogenes after Oral Exposure in Pregnant Guinea Pigs. Journal of Food Protection. 70 (5), 1122–1128.
  290. ↑ Golnazarian CA, Donnelly CW, Pintauro SJ and Howard DB Comparison of infectious dose of Listeria monocytogenes F5817 as determined for normal versus compromised C57B1/6J mice. Journal of food protection. 52 (10), 696–701.
  291. ↑ Golnazarian CA, Donnelly CW, Pintauro SJ and Howard DB Comparison of infectious dose of Listeria monocytogenes F5817 as determined for normal versus compromised C57B1/6J mice. Journal of food protection. 52 (10), 696–701.
  292. ↑ Czuprynski CJ, Faith NG and Steinberg H (2003) A/J Mice Are Susceptible and C57BL/6 Mice Are Resistant to Listeria monocytogenes Infection by Intragastric Inoculation. Infection and Immunity. 71 (2), 682–689.
  293. ↑ Czuprynski CJ, Faith NG and Steinberg H (2003) A/J Mice Are Susceptible and C57BL/6 Mice Are Resistant to Listeria monocytogenes Infection by Intragastric Inoculation. Infection and Immunity. 71 (2), 682–689.
  294. ↑ Golnazarian CA, Donnelly CW, Pintauro SJ and Howard DB Comparison of infectious dose of Listeria monocytogenes F5817 as determined for normal versus compromised C57B1/6J mice. Journal of food protection. 52 (10), 696–701.
  295. ↑ Audurier A, Pardon P, Marly J and Lantier F (1980) Experimental infection of mice with Listeria monocytogenes and L. innocua. Annales de microbiologie. 131B (1), 47–57.
  296. ↑ Lawin-Brüssel CA, Refojo MF, Leong FL, Hanninen L and Kenyon KR (1993) Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea. 12 (1), 10–18.
  297. ↑ Lawin-Brüssel CA, Refojo MF, Leong FL, Hanninen L and Kenyon KR (1993) Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea. 12 (1), 10–18.
Retrieved from "http://qmrawiki.canr.msu.edu/index.php?title=Dosing_Experiments&oldid=13471"